As of December 2024, Guilin Sanjin Pharmaceutical has a market cap of $1.22B. This makes Guilin Sanjin Pharmaceutical the world's 7055th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.10B | -5.73% |
2023 | $1.17B | 9.61% |
2022 | $1.06B | -21.82% |
2021 | $1.36B | 13.41% |
2020 | $1.20B | 13.64% |
2019 | $1.06B | 2.50% |
2018 | $1.03B | -20.99% |
2017 | $1.30B | -11.81% |
2016 | $1.48B | -21.16% |
2015 | $1.88B | 26.98% |
2014 | $1.48B | 20.01% |
2013 | $1.23B | 10.56% |
2012 | $1.11B | - |